Trial Profile
Comparison of first line Crizotinib versus chemotherapy in pateints with advanced non small cell lung cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jul 2018
Price :
$35
*
At a glance
- Drugs Crizotinib (Primary) ; Carboplatin; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms PROFILE 1029
- 22 Jul 2018 New trial record
- 29 Jun 2018 Results published in the Journal of Thoracic Oncology